Abstract

BackgroundHIV remains a significant public health dilemma in West and Central Africa. HIV-related morbidity and mortality are unjustly high, yet little is known about the spectrum of complicating comorbidities in HIV-positive patients who are admitted to hospitals in these regions.MethodsThis study involved a retrospective chart review to determine the common comorbidities and mortality rate of HIV-infected patients admitted over a six month period to the internal medicine service at the Komfo Anokye Teaching Hospital (KATH), a tertiary care center in Ghana. Patients admitted with a known or new HIV diagnosis from January to July 2016 were included. Data were collected regarding the number of new versus known cases admitted, the most common presenting complaints, final admitting diagnoses, and causes of mortality in these patients.ResultsDuring the six-month study period, 250 HIV-positive patients were admitted to KATH, and 245 of these individuals had valid survival time recorded. Of these patients, 145/245 (59.2%) were female. Median age of patients included in the study was 42 years old (IQR 35–51). The mortality rate for HIV patients admitted to the hospital was 35.5% (87 patients). One hundred and forty-five (59.4%) patients had a known history of HIV documented in their patient charts, while the remaining patients were newly diagnosed with HIV during their inpatient stay. Pulmonary tuberculosis predominated among diagnostic findings, with 40.4% of HIV-infected patients diagnosed with the condition while admitted. Patients presenting with neurological symptoms on admission were 2.14 (95% CI: 1.27–3.61) times more likely to die than those without neurological symptoms (p = .004).ConclusionsOver 40% of HIV-positive patients admitted to KATH were newly diagnosed with HIV at admission. While pulmonary tuberculosis was the most common co-morbidity, patients presenting with neurological symptoms were at higher risk of death. This study suggests that enhanced outpatient screening is needed for early diagnosis and prompt HAART initiation, as well as increased access to diagnostic modalities and treatment for HIV-positive patients with neurological symptoms.

Highlights

  • Human Immunodeficiency Virus (HIV) remains a significant public health dilemma in West and Central Africa

  • The INSIGHT [20] and TEMPRANO [21] trials have led to the World Health Organization (WHO)’s 2015 recommendations for initiation of ART in all patients regardless of CD4 count [22]. In light of these recommendations and targets, our aim was to investigate the rate of known versus new HIV diagnosis as well as morbidity and mortality outcomes for HIV-positive patients admitted to the internal medicine department at the Komfo Anokye Teaching Hospital (KATH) in order to contribute to the development of strategies to improve care of individuals with HIV infection in Ghana

  • During the six-month study period, 250 HIV-positive patients were admitted to the KATH internal medicine service and 245 of these individuals had valid survival time recorded

Read more

Summary

Introduction

HIV remains a significant public health dilemma in West and Central Africa. HIV-related morbidity and mortality are unjustly high, yet little is known about the spectrum of complicating comorbidities in HIV-positive patients who are admitted to hospitals in these regions. Patients continue to present to inpatient care with WHO Class III and IV illness and undiagnosed or untreated HIV infection as a result of insufficient case finding, poor linkage to care and treatment failure or default [3, 4, 8,9,10,11,12]. This undoubtedly contributed to the 310,000 AIDS-related deaths that were reported in 2016 in western and central Africa [1]. In the nation of Ghana in the geographic region of West Africa, 230,000 adults were living with HIV in 2015 [13], but in this population there are currently limited morbidity and mortality studies of HIV-positive adults presenting to hospital

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call